Other
Salix Pharma will buy Santarus for $2.12 billion
Salix Pharmaceuticals will buy Santarus for about $2.12 billion to add to its roster of drugs.
Nov 7, 2013
0
0
News tagged with stock price
Other
US wants more information from Roche on Illumina bid
Swiss pharmaceutical group Roche said Tuesday the US Federal Trade Commission had requested additional information on its hostile $5.7-billion (4.2 billion euros) bid for US gene mapper Illumina.
Mar 13, 2012
0
0
Medications
Roche extends its hostile takeover bid for Illumina
Swiss pharmaceutical group Roche said Monday it is sticking by its hostile $5.7-billion (4.2 billion euros) bid for US gene mapper Illumina and is extending it for a month.
Feb 27, 2012
0
0
Other
Company stock prices before public announcements of oncology trial results
Prior knowledge of phase III clinical trials of new drugs and Food and Drug Administration (FDA) regulatory decisions may affect the price of a drug company's stock according to a study published September 26 in the Journal ...
Sep 26, 2011
0
0
